Jane Street’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-207,401
| Closed | -$226K | – | 5969 |
|
|
2025
Q1 | $226K | Buy |
207,401
+152,726
| +279% | +$166K | ﹤0.01% | 4870 |
|
|
2024
Q4 | $54.7K | Sell |
54,675
-15,624
| -22% | -$15.6K | ﹤0.01% | 5468 |
|
|
2024
Q3 | $116K | Buy |
70,299
+38,553
| +121% | +$63.6K | ﹤0.01% | 5429 |
|
|
2024
Q2 | $35.2K | Sell |
31,746
-26,777
| -46% | -$29.7K | ﹤0.01% | 5800 |
|
|
2024
Q1 | $77.3K | Buy |
+58,523
| New | +$77.3K | ﹤0.01% | 5317 |
|
|
2023
Q3 | – | Sell |
-13,157
| Closed | -$33K | – | 5397 |
|
|
2023
Q2 | $33K | Buy |
+13,157
| New | +$33K | ﹤0.01% | 5007 |
|
|
2023
Q1 | – | Sell |
-71,503
| Closed | -$100K | – | 5870 |
|
|
2022
Q4 | $100K | Buy |
+71,503
| New | +$100K | ﹤0.01% | 4692 |
|
|
2022
Q3 | – | Sell |
-69,345
| Closed | -$241K | – | 6018 |
|
|
2022
Q2 | $241K | Buy |
69,345
+55,533
| +402% | +$193K | ﹤0.01% | 4291 |
|
|
2022
Q1 | $156K | Sell |
13,812
-15,595
| -53% | -$176K | ﹤0.01% | 4820 |
|
|
2021
Q4 | $281K | Buy |
+29,407
| New | +$281K | ﹤0.01% | 4093 |
|
|
2021
Q1 | – | Sell |
-31,967
| Closed | -$489K | – | 5169 |
|
|
2020
Q4 | $489K | Buy |
+31,967
| New | +$489K | ﹤0.01% | 2780 |
|
|
2017
Q4 | – | Sell |
-335
| Closed | -$68K | – | 3262 |
|
|
2017
Q3 | $68K | Sell |
335
-113
| -25% | -$22.9K | ﹤0.01% | 2770 |
|
|
2017
Q2 | $52K | Sell |
448
-97
| -18% | -$11.3K | ﹤0.01% | 2749 |
|
|
2017
Q1 | $87K | Sell |
545
-50
| -8% | -$7.98K | ﹤0.01% | 2633 |
|
|
2016
Q4 | $104K | Sell |
595
-94
| -14% | -$16.4K | ﹤0.01% | 2458 |
|
|
2016
Q3 | $169K | Sell |
689
-175
| -20% | -$42.9K | ﹤0.01% | 2553 |
|
|
2016
Q2 | $214K | Sell |
864
-232
| -21% | -$57.5K | ﹤0.01% | 2312 |
|
|
2016
Q1 | $398K | Sell |
1,096
-370
| -25% | -$134K | ﹤0.01% | 1737 |
|
|
2015
Q4 | $676K | Buy |
+1,466
| New | +$676K | ﹤0.01% | 1348 |
|
|
2014
Q3 | – | Sell |
-495
| Closed | -$540K | – | 2441 |
|
|
2014
Q2 | $540K | Buy |
+495
| New | +$540K | 0.01% | 1121 |
|